Technical Analysis for CMPS - COMPASS Pathways Plc

Grade Last Price % Change Price Change
F 48.32 7.55% 3.39
CMPS closed up 7.55 percent on Friday, January 22, 2021, on 85 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Up
Historical CMPS trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion 7.55%
50 DMA Resistance Bearish 7.81%
Bearish Engulfing Bearish 7.81%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 7.81%
Wide Bands Range Expansion 7.81%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 6.60%
Narrow Range Bar Range Contraction 6.60%
Older End-of-Day Signals for CMPS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


COMPASS Pathways Plc Description

COMPASS Pathways plc is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support. COMP360 has been designated a Breakthrough Therapy by the US Food and Drug Administration (FDA), for treatment-resistant depression (TRD), and we are currently conducting a phase IIb clinical trial of psilocybin therapy for TRD, in 20 sites across Europe and North America. We are headquartered in London, UK, with offices in New York, USA. Our vision is a world of mental wellbeing.


Sector: Other
Industry: Other
Keywords: Health Sciences Drug Discovery Mental Health FDA Psychoactive Drugs Entheogens Major Depressive Disorder Depression Breakthrough Therapy MP3 Treatment Resistant Depression

Is CMPS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 61.69
52 Week Low 22.53
Average Volume 337,094
200-Day Moving Average 0.00
50-Day Moving Average 46.57
20-Day Moving Average 46.85
10-Day Moving Average 44.22
Average True Range 3.99
ADX 19.08
+DI 24.91
-DI 19.13
Chandelier Exit (Long, 3 ATRs ) 48.90
Chandelier Exit (Short, 3 ATRs ) 51.06
Upper Bollinger Band 55.69
Lower Bollinger Band 38.02
Percent B (%b) 0.58
BandWidth 37.73
MACD Line -1.07
MACD Signal Line -1.06
MACD Histogram -0.0089
Fundamentals Value
Market Cap 1.68 Billion
Num Shares 34.8 Million
Price-to-Sales 0.00
Price-to-Book 7.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 55.40
Resistance 3 (R3) 54.88 52.00 54.22
Resistance 2 (R2) 52.00 50.20 52.26 53.83
Resistance 1 (R1) 50.16 49.08 51.08 50.68 53.43
Pivot Point 47.28 47.28 47.74 47.54 47.28
Support 1 (S1) 45.44 45.48 46.36 45.96 43.21
Support 2 (S2) 42.56 44.36 42.82 42.81
Support 3 (S3) 40.72 42.56 42.42
Support 4 (S4) 41.24